Navigation Links
Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award
Date:2/5/2013

5 February 2013 EMBO and the Federation of European Biochemical Societies (FEBS) announce Genevive Almouzni, deputy director of the Institut Curie in Paris, France, as the winner of the 2013 FEBS | EMBO Women in Science Award.

Professor Almouzni has been recognized for her outstanding contributions to research in the area of histones and chromatin, her engagement in promoting epigenetics in Europe, and her active role in mentoring female scientists.

The FEBS | EMBO Women in Science Award rewards the exceptional achievements of a female researcher in molecular biology over the previous five years. Winners of the award are role models who inspire future generations of women in science.

Almouzni has investigated the basic mechanisms involved in chromatin assembly from the nucleosome to higher order structures such as those found in heterochromatin domains. The dynamics of this organization in the context of cell cycle, development as well as genotoxic stresses have been central to her research. "Her work has greatly extended our understanding of chromatin assembly and DNA repair," said Sir John Gurdon, winner of the 2012 Nobel Prize in Physiology or Medicine, who worked with the award winner on examining aspects of nuclear reprogramming involving histone variants.

"It is a great honor for all scientists who work in the field of chromatin and epigenetics, particularly for all women in science," said the award winner upon hearing of her distinction.

The French scientist has been an inspiring mentor and motivator for other women in science throughout her career at the Institut Curie. She is also highly engaged with the European scientific community as the coordinator and member of international projects such as the FP6 Epigenome Network of Excellence and the FP7 European Network of Excellence EpiGeneSys. Her publishing record encompasses more than 160 papers and she sits on numerous committees and editorial boards including the advisory editorial board of The EMBO Journal. "Her capacity to succeed at all levels and still have the time and energy for others is admirable," stated her colleague Edith Heard, Research Unit director at the Institut Curie.

The 2013 FEBS | EMBO Women in Science Award of 10,000 euros will be presented to Genevive Almouzni on 9 July at the FEBS Congress in St. Petersburg, Russia, where she will give a special lecture. Nominations for the 2014 FEBS | EMBO Women in Science Award close on 15 October 2013. For more information, please visit: http://www.embo.org/policy-and-society/women-in-science/women-in-science-award.html or http://www.febs.org/women-award.

Biosketch

Genevive Almouzni studied biology at the cole Normale Suprieure in Paris. She completed her PhD at the University of Paris 6 and started her professional career in the laboratory of Marcel Mchali, where she managed to identify critical molecular mechanisms regulating DNA replication and chromatin assembly. After completing a CNRS research assistant position in 1991, she moved to the lab of Alan Wolffe, a scientist who turned the chromatin field into a mainstream research subject. In 1994, Genevive Almouzni was awarded a junior investigator grant of the CNRS and started as a junior group leader at the Institut Curie.

She has held appointments as head of research unit and deputy director of the Institut Curie. The French scientist received the silver medal of the CNRS and became a member of the scientific advisory board of the European Molecular Biology Laboratory and Panel Member of the European Research Council (ERC). Recently, she received an ERC Advanced Investigator grant and obtained a Laboratory of Excellence grant from the French Ministry of Research. She has served as elected member of the EMBO Council since 2011.


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. DigitalPersona Fingerprint Readers Receive STQC Certification for UIDAI Program in India
2. Xenon Receives a Milestone Payment for Marketing Approval of Glybera in Europe
3. Brainwave "Balancing" Research Receives $1 Million Grant From The Susanne Marcus Collins Foundation, Inc.
4. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
5. Univ. of Miami profs Chen and Soden named Fellows of AMS, Albrecht receives AMS Teaching Award
6. Childrens Hospital of Philadelphia receives federal grant to improve health care decision-making
7. Bloomberg School receives $28 million for family planning advocacy
8. UC Riverside turfgrass specialist receives high honor
9. University of Illinois receives grant to study ozone resistance in corn
10. Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
11. CU-led team receives $9.2 million DOE grant to engineer E. coli into biofuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 ... Driven largely by the confluence of organizations, desires ... distaste for knowledge-based systems (password and challenge questions), ... industrial, and government systems. The market is driven ... a demarcation between consumer and enterprise uses cases, ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... MENLO PARK, Calif. and ... -- Longitude Capital, a private investment firm focused on ... today announced the promotion of Josh Richardson ... Richardson focuses on investments in biotechnology companies.  He ... and has played important roles in Longitude,s investments ...
(Date:2/16/2017)... , Feb. 16, 2017 Research ... "Synthetic Biology: Global Markets" report to their offering. ... ... (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic ... and assembly, genome editing, bioinformatics and specialty media) and ...
(Date:2/16/2017)... February 16, 2017 Patient ... of innovative telemedicine application, new and leading edge ... experiencing a boom worldwide. The healthcare sector as ... technologies, services and new therapies for companies such ... RHT), Cellectar Biosciences, Inc. (NASDAQ: CLRB ...
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
Breaking Biology Technology: